A phase 1 study to evaluate the safety and pharmacokinetics of medimmune (medi8852) in healthy adults

Authors
Category Primary study
JournalOpen Forum Infectious Diseases
Year 2016
This article has no abstract
Epistemonikos ID: b7768ff0d8f69eb90e2e450fcf185e91b2902ef5
First added on: Feb 10, 2025